ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Survival"

  • 2021 American Transplant Congress

    20 Year Survival Following Lung Transplantation

    R. M. Reul, Jr1, S. Barrett1, A. Alnajar2, J. Dunson1, P. S. Garcha3, G. Loor4, J. A. Goss4, A. A. Rana4

    1Office of Student Affairs, Baylor College of Medicine, Houston, TX, 2Department of Surgery, University of Miami Health System, Miami, FL, 3Department of Medicine, Baylor College of Medicine, Houston, TX, 4Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX

    *Purpose: Outcomes following lung transplantation (LTx) have been poor compared to those of heart, liver, and kidney transplants, with 5-year survival rates around 50%. To…
  • 2021 American Transplant Congress

    The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Meld and Exception Statuses

    A. Wey1, S. Noreen2, S. Gentry3, N. Salkowski1, M. Cafarella2, R. Hirose4, J. Trotter5, D. Segev6, A. Israni1, J. Snyder1, B. Kasiske1

    1SRTR, Minneapolis, MN, 2UNOS, Richmond, VA, 3USNA, Annapolis, MD, 4Univ of San Francisco, San Francisco, CA, 5BSW Health, Dallas, TX, 6Johns Hopkins, Baltimore, MD

    *Purpose: Acuity circles (AC) allocation was implemented on February 4, 2020. AC significantly changed the relative priority of candidates with allocation PELD/MELD scores of 29…
  • 2021 American Transplant Congress

    Patient Survival After Living Donor Kidney Donation

    M. G. Naik, K. Sakurayama, K. Budde, F. Halleck

    Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité, Berlin, Germany

    *Purpose: Living donor kidney transplantation [LDKT] is associated with best patient survival and life quality among kidney replacement therapies in case of chronic kidney disease.…
  • 2021 American Transplant Congress

    Outcomes After Abo Incompatible Pediatric Liver Transplantation are Comparable to Abo Identical/compatible Transplant

    C. Lemoine, K. Brandt, R. Superina

    Division of Transplant and Advanced Hepatobiliary Surgery, Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL

    *Purpose: In order to evaluate if the incidence of vascular and biliary complications as well as patient and graft survival in ABO incompatible (ABOi) liver…
  • 2021 American Transplant Congress

    Adult Combined Liver-Heart Transplantation: The United States Experience

    I. A. Ziogas1, S. P. Alexopoulos1, W. K. Wu1, L. K. Matsuoka1, M. A. Rauf1, M. Izzy2, R. Perri2, K. H. Schlendorf3, J. N. Menachem3, A. S. Shah4

    1Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, 2Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, TN, 3Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, 4Department of Cardiac Surgery, Vanderbilt University Medical Center, Nashville, TN

    *Purpose: Combined heart-liver transplantation (CHLT) is now being practiced with increasing regularity and improved outcomes in the United States. We performed the most comprehensive review…
  • 2021 American Transplant Congress

    Overall Survival by Best Overall Response with Tabelecleucel in Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease After Solid Organ Transplant

    S. Prockop1, L. Gamelin2, R. Dinavahi2, Y. Sun2, N. Guzman-Becerra2, H. Parmar2

    1Memorial Sloan Kettering Cancer Center, New York, NY, 2Atara Biotherapeutics, South San Francisco, CA

    *Purpose: Tabelecleucel is an investigational, off-the-shelf, allogeneic Epstein-Barr virus (EBV)-specific T-cell immunotherapy being studied in patients (pts) with serious EBV-driven diseases, including post-transplant lymphoproliferative disease…
  • 2021 American Transplant Congress

    Successful Prophylaxis of Antibody-Mediated Rejection by Downregulation of C5 Expression via RNA Interference in a Rat Kidney Transplant Model

    H. Ishigooka1, S. Motoi2, T. Yamakawa1, C. Matsui2, Y. Suzuki3, R. Ishii1, K. Saiga1, D. Tokita1, T. Imai2, K. Tanabe1

    1Urology, Tokyo Women's Medical University, Tokyo, Japan, 2KAN Research Institute, Inc., Kobe, Japan, 3Tsukuba Research Laboratories, Eisai, Co., Ltd., Ibaraki, Japan

    *Purpose: Antibody-mediated rejection (AMR) is a major contributor towards poor prognosis in kidney transplantation. Circulating donor-specific antibodies (DSAs) cause AMR with complement activation. This study…
  • 2021 American Transplant Congress

    Very Long-Term Patient and Kidney Allograft Outcomes in Kidney Transplant Recipients More Than 20 Years After Transplantation:

    T. Schachtner, A. Reimann, T. Müller

    University Hospital Zurich, Zürich, Switzerland

    *Purpose: Despite rapid medical advancements in the field of transplantation over the last decades, long-term kidney allograft survival only slowly improves. Especially little is known…
  • 2021 American Transplant Congress

    Macrosteatosis in the US Pediatric Deceased Liver Donor Population, 2005-2018

    J. Purvis, D. Dhall, C. McLeod, S. Sheikh, R. Cannon, K. Frey, J. Locke, B. Orandi

    University of Alabama School of Medicine, Birmingham, AL

    *Purpose: The pediatric obesity epidemic is associated with early signs of non-alcoholic fatty liver disease (NAFLD) such as increased hepatic macrosteatosis and liver enzymes. In…
  • 2021 American Transplant Congress

    Outcomes of Downstaging Hepatocellular Carcinoma (HCC) to within Milan Criteria Before Liver Transplantation (LT): A Multicenter Analysis of the “All-comers” Protocol

    B. Natarajan1, P. Tabrizian2, M. Hoteit3, C. Frenette4, T. Ghaziani5, R. Dhanasekaran5, N. Parikh6, J. Guy7, A. Shui1, S. Florman2, F. Yao1, N. Mehta1

    1UCSF, SF, CA, 2Mt Sinai, NY, NY, 3U Penn, Philadelphia, PA, 4Scripps, La Jolla, CA, 5Stanford, Palo Alto, CA, 6U Michigan, Ann Arbor, MI, 7CPMC, SF, CA

    *Purpose: Patients with HCC meeting UNOS-downstaging (DS) criteria (1 lesion 5.1-8 cm, 2-3 lesions at least one 3.1-5 cm and total tumor diameter (TTD) ≤8…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 66
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences